Raiffeisen Bank International’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Sell
4,650
-2,098
-31% -$523K 0.01% 382
2025
Q4
$1.64M Sell
6,748
-3,668
-35% -$938K 0.02% 275
2025
Q3
$2.82M Sell
10,416
-1,068
-9% -$292K 0.04% 212
2025
Q2
$2.96M Sell
11,484
-36
-0.3% -$8.59K 0.04% 191
2025
Q1
$2.53M Buy
11,520
+2,423
+27% +$566K 0.04% 201
2024
Q4
$2.09M Buy
+9,097
New +$2.19M 0.03% 212

Other funds holding RMD

Raiffeisen Bank International's RMD Position: Q1 2026 in Review

Raiffeisen Bank International reduced its ResMed (RMD) stake by 31% in Q1 2026, selling an estimated $523K and leaving 4,650 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #382.

Raiffeisen Bank International first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.96M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Raiffeisen Bank International held 4,650 shares of ResMed worth $1.02M as of Q1 2026.
  • Raiffeisen Bank International sold 2,098 ResMed shares in Q1 2026, an estimated $523K.
  • ResMed made up 0.01% of Raiffeisen Bank International's portfolio in Q1 2026, its #382 holding.
  • Raiffeisen Bank International first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Raiffeisen Bank International's ResMed position peaked at $2.96M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Raiffeisen Bank International's 13F filing for Q1 2026, filed 24 Apr 2026.